0001214659-23-016097.txt : 20231206 0001214659-23-016097.hdr.sgml : 20231206 20231206170141 ACCESSION NUMBER: 0001214659-23-016097 CONFORMED SUBMISSION TYPE: 4/A PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20231116 FILED AS OF DATE: 20231206 DATE AS OF CHANGE: 20231206 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Krogulski Kenneth CENTRAL INDEX KEY: 0001695580 FILING VALUES: FORM TYPE: 4/A SEC ACT: 1934 Act SEC FILE NUMBER: 001-33637 FILM NUMBER: 231470365 MAIL ADDRESS: STREET 1: 2525 WEST END AVENUE, SUITE 950 CITY: NASHVILLE STATE: TN ZIP: 37203 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: CUMBERLAND PHARMACEUTICALS INC CENTRAL INDEX KEY: 0001087294 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 2525 WEST END AVENUE STREET 2: SUITE 950 CITY: NASHVILLE, STATE: TN ZIP: 37203 BUSINESS PHONE: 615-255-0068 MAIL ADDRESS: STREET 1: 2525 WEST END AVENUE STREET 2: SUITE 950 CITY: NASHVILLE STATE: TN ZIP: 37203 4/A 1 marketforms-63722.xml PRIMARY DOCUMENT X0508 4/A 2023-11-16 2023-11-30 0001087294 CUMBERLAND PHARMACEUTICALS INC CPIX 0001695580 Krogulski Kenneth 1600 WEST END AVE., SUITE 1300 NASHVILLE TN 37203 true false false false 1 Common Stock 2023-11-16 5 L false E 66 1.73 A 227925 D Common Stock 2023-11-17 5 L false E 280 1.83 A 228205 D Common Stock 2023-11-20 5 L false E 268 1.70 A 228473 D Common Stock 2023-11-21 5 L false E 125 1.76 A 228598 D Common Stock 2023-11-22 5 L false E 280 1.74 A 228878 D Common Stock 2023-11-27 5 L false E 379 1.86 A 229257 D Common Stock 2023-11-28 5 L false E 124 1.68 A 229381 D Common Stock 2023-11-29 5 L false E 165 1.73 A 229546 D Common Stock 2023-11-30 5 L false E 324 1.66 A 229870 D The reported purchases occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May16, 2023. Kenneth J. Krogulski by /s/ John Hamm as attorney-in-fact 2023-12-06